Opiant Pharmaceuticals Inc. | Balance Sheet
Fiscal year is August-July. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
598.60
254.80
434.20
1,481.40
6,872.60
24,613.60
Total Accounts Receivable
-
-
-
312.50
3,750.00
4,489.30
Other Current Assets
21.30
24.10
33.10
62.40
164.90
267.60
Total Current Assets
619.90
278.80
467.40
1,856.30
10,787.40
29,370.60
Net Property, Plant & Equipment
-
-
-
6.50
2.80
-
Intangible Assets
23.20
21.80
20.40
19.10
17.70
15.70
Total Assets
643.10
300.70
487.80
1,881.90
10,807.90
29,386.30
ST Debt & Current Portion LT Debt
375.00
350.00
130.00
165.00
-
Accounts Payable
40.80
-
315.50
140.60
2,212.00
Other Current Liabilities
467.30
1,617.30
3,129.10
3,931.30
1,955.00
Total Current Liabilities
883.10
1,967.30
3,574.50
4,236.80
4,166.90
Other Liabilities
750.00
1,411.50
5,300.00
2,350.00
2,306.50
Total Liabilities
1,633.10
3,378.70
8,874.50
6,586.80
6,473.50
Common Equity (Total)
990.00
3,078.10
8,386.70
4,705.00
4,334.40
Total Shareholders' Equity
990.00
3,078.10
8,386.70
4,705.00
4,334.40
Total Equity
990.00
3,078.10
8,386.70
4,705.00
4,334.40
Liabilities & Shareholders' Equity
643.10
300.70
487.80
1,881.90
10,807.90
About Opiant Pharmaceuticals
View Profile
